Are you aware that within the Unit of Hereditary Digestive Tract Tumors of the IRCCS National Cancer Institute of Milan where you are under surveillance/treatment, there is a registry dedicated to the management (surveillance and treatment) of your condition? ] than in those who did not, albeit with borderline significance (raw p value: 0.043).
← all excerpts
Hereditary colorectal cancer syndromes and the COVID-19 pandemic: results from a survey conducted in patients enrolled in a dedicated registry.
1
—
—